Use of antiarrhythmic compounds in the prevention of post-infarc

Details Use of antiarrhythmic compounds in the prevention of post-infarc Use of antiarrhythmic compounds in the prevention of post-infarc

1997-03-17

1999-11-16

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3134

Patent

active

059859156

ABSTRACT:
The subject of the invention is a method for reducing mortality of cardiac origin in patients having a reduced left ventricular function after myocardial infarction, without rhythm disorders requiring an antiarrhythmic treatment, consisting in administering to said patients an effective amount of one or more active ingredients selected from benzofuran derivatives with antiarrhythmic activity and pharmaceutically acceptable salts thereof in combination with one or more pharmaceutically acceptable vehicles.

REFERENCES:
patent: 5223510 (1993-06-01), Gubin et al.
Am. J. Cardiol., vol. 72, No. 16, 1993, pp. 70f-74f, XP000607627.
Ann. Inter. Med., vol. 122, No. 9, 1995, pp. 689-700, XP000607576.
Chew et al.--J. Cardiovasc. Pharmacoc. vol. 4 (6), 1028-36 (Abstract), 1982.
Patterson et al--Circulation (Med. Sch., Univ. of Mich.) vol. 68 (4) 857-64 (Abstract), 1983.
Seidl et al.--Ptsch. Med. Wochenschr. vol. 120 (18), 656-60, Germany (Abstract), 1995.

Affiliated with

Also associated with

Rating

Use of antiarrhythmic compounds in the prevention of post-infarc does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of antiarrhythmic compounds in the prevention of post-infarc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antiarrhythmic compounds in the prevention of post-infarc will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1325299